ReNeuron logo
ReNeuron logo

August 2020 – Proactive Investors: One2One Virtual Conference

https://youtu.be/HjMglJPChJA

July 2020 – Proactive Investors: ReNeuron’s Michael Hunt says key focus now is to build dataset for retinal disease study

Preliminary Results Presentation for the year ended 31 March 2020

To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.

ARM Cell & Gene : Meeting on the Med – 23-25 April 2019

Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation

To view the presentation please click here…

Proactive Investors : “ReNeuron Group agrees £80mln cell therapy licensing deal for China”

https://www.youtube.com/watch?v=H3Ny1KbHusg

Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’

https://youtu.be/ADBu4Uy7ZZ0

Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’

Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma”

https://www.youtube.com/watch?v=wa47CfniyLQ

Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma”

https://www.youtube.com/watch?v=wa47CfniyLQ

Section: News

  • News

© ReNeuron Group plc 2025 All rights reserved

Website design by Carr Kamasa Design

  • Privacy Notice
  • Disclaimer